(Q53893408)

English

First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

title

First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine (English)

reason for deprecated rank

marking inconsistent with the registered/official identifier/name

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4994424

retrieved

26 March 2023

author name string

D. de Biolley

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4994424

retrieved

26 March 2023

L. Sorel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4994424

retrieved

26 March 2023

language of work or name

French

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

4994424

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4994424

retrieved

26 March 2023

publication date

1 November 1969

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

published in

Acta neurologica et psychiatrica Belgica

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

volume

69

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

page(s)

909-913

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

Identifiers

PubMed publication ID

4994424

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4994424

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/4994424

(Q53893408)

First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)